TACE OR TAE FOR TREATMENT OF HEPATOCELLULAR CARCINOMA?

被引：0
|
作者：
Meredith, P. [1 ]
Kohler, K. [1 ]
Jeffries-Chung, C. [1 ]
See, T-C [2 ]
Griffiths, W. J. [1 ]
机构：
[1] Cambridge Univ Hosp, Dept Hepatol, Cambridge, England
[2] Cambridge Univ Hosp, Dept Radiol, Cambridge, England
来源：
GUT | 2012年 / 61卷
关键词：
D O I：
10.1136/gutjnl-2012-302514d.274
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A409 / A409
页数：1
相关论文
共 50 条
  • [31] Recurrence of Hepatocellular Carcinoma After Transarterial Chemoembolization (TACE) Alone and TACE in Combination With Other Treatment Modalities
    Balogh, J.
    Islam, A.
    Saharia, A.
    Monsour, H.
    Burroughs, S. Gordon
    Weiner, M.
    Gaber, A.
    Ghobrial, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [32] Treatment of hepatocellular carcinoma by transarterial embolization (TAE). A prospective placebo controlled trial.
    Bruix, J
    Llovet, JM
    Castells, A
    Bru, C
    Montanya, X
    Vilana, R
    Ayuso, MC
    Rodes, J
    HEPATOLOGY, 1997, 26 (04) : 482 - 482
  • [33] IMPACT OF PRIOR TACE/TAE ON THE EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) FROM THE ASIA-PACIFIC REGION
    Tak, W. Y.
    Yu, S.
    Tsao, C. J.
    Yang, T. S.
    Kim, J. S.
    Qin, S.
    Burock, K.
    Zou, J.
    Voliotis, D.
    Cheng, A. L.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S301 - S301
  • [34] TREATMENT OPTIONS IN INTERMEDIATE STAGE (BCLC B) HEPATOCELLULAR CARCINOMA: NOT ALWAYS TACE
    Pascual, Sonia
    Miralles, Cayetano
    Irurzun, Javier
    Bernabe, Juan M.
    Herrera, Ivan
    Hurtado, Ana
    Rodriguez, Maria
    Bellot, Pablo
    Gomez, Lucia
    HEPATOLOGY, 2022, 76 : S1371 - S1372
  • [35] The Role of Lipiodol in the Treatment of Hepatocellular Carcinoma (HCC) through Transarterial Chemoembolization (TACE)
    Popa, Bogdan Valeriu
    Bratu, Ana Magdalena
    Minoiu, Costin Aurelian
    Turculet, Claudiu
    Ene, Dragos
    Constantinescu, Gabriel
    Ilie, Madalina
    Popescu, Mina
    Badila, Elisabeta
    REVISTA DE CHIMIE, 2015, 66 (03): : 408 - 412
  • [36] Gangrenous Cholecystitis Related to Transcatheter Arterial Chemoembolization (TACE) Treatment for Hepatocellular Carcinoma
    Karavias, Dimitrios
    Kourea, Helen
    Sotiriadi, Athanasia
    Karnabatidis, Dimitrios
    Karavias, Dionissios
    JOURNAL OF GASTROINTESTINAL SURGERY, 2015, 19 (11) : 2093 - 2095
  • [37] Arterial infusion of rapamycin in the treatment of rabbit hepatocellular carcinoma to improve the effect of TACE
    Wu, Tao
    Yao, Yihui
    Sun, Ruimin
    Wang, Huili
    Yin, Xiaoxiang
    Zhang, Junna
    Zhou, Qing
    Huangfu, Chaoshen
    OPEN LIFE SCIENCES, 2018, 13 (01): : 299 - 304
  • [38] Analgesic effects of indomethacin suppositories after TACE in the treatment of unresectable hepatocellular carcinoma
    Zhang, Jiacheng
    Du, Peng
    Lu, Wei
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 128 : 18 - 18
  • [39] Gangrenous Cholecystitis Related to Transcatheter Arterial Chemoembolization (TACE) Treatment for Hepatocellular Carcinoma
    Dimitrios Karavias
    Helen Kourea
    Athanasia Sotiriadi
    Dimitrios Karnabatidis
    Dionissios Karavias
    Journal of Gastrointestinal Surgery, 2015, 19 : 2093 - 2095
  • [40] Treatment effect of liver resection vs. RFA or TACE in hepatocellular carcinoma
    Strobel, O.
    Buechler, M. W.
    CHIRURG, 2018, 89 (01): : 64 - 64
12345